A group of investors led a $136m round in Impulse Dynamics.

A group of investors, including Perceptive Advisors, Redmile Group, Alger, and Hobart Healthcare, led a $136m round in Impulse Dynamics, a global medical device company with participation from Acorn Bioventures. “This round of funding will accelerate our business, both commercially and with our pipeline of advanced technology innovation,” said Jason Spees, Impulse Dynamics CEO.